Last year, Johnson & Johnson generated 108.54B USD for its biggest-performing segment, Oncology-DARZALEX. The United States made the largest contribution, accounting for 53.75B USD last year. For the latest quarter, Johnson & Johnson reported the revenue of 29.52B USD for the period ending 2026-06-28, which came from the top-performing segment, Oncology-DARZALEX. United States contributed the highest revenue, at 14.53B USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Oncology-DARZALEX

Immunology-STELARA

Cardiovascular-ELECTROPHYSIOLOGY

MedTech-Cardiovascular-ELECTROPHYSIOLOGY

Surgery-General

MedTech-Surgery-General

Immunology-TREMFYA

Surgery-Advanced

MedTech-Surgery-Advanced

Vision-Contact Lenses/Other

MedTech-Vision-Contact Lenses/Other

Neuroscience-INVEGASUSTENNA/XEPLION/INVEGATRINZA/TREVICTA

Oncology-ERLEADA

Orthopaedics-Trauma

MedTech-Orthopaedics-Trauma

Orthopaedics-SPINE, SPORTS & OTHER

MedTech-Orthopaedics-SPINE, SPORTS & OTHER

Oncology-IMBRUVICA

Immunology-SIMPONI/SIMPONI ARIA

Cardiovascular/Metabolism/Other-XARELTO

Pulmonary Hypertension-OPSUMIT/OPSYNVI

Pulmonary Hypertension-OPSUMIT

Pulmonary Hypertension-UPTRAVI

Oncology-CARVYKTI

Immunology-REMICADE

Cardiovascular-ABIOMED

MedTech-Cardiovascular-ABIOMED

Neuroscience-SPRAVATO

Orthopaedics-Hips

MedTech-Orthopaedics-Hips

Orthopaedics-Knees

MedTech-Orthopaedics-Knees

Infectious Diseases-PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA

Vision-Surgical

MedTech-Vision-Surgical

Infectious Diseases- EDURANT/rilpivirine

Cardiovascular-SHOCKWAVE

MedTech-Cardiovascular-SHOCKWAVE

Cardiovascular/Metabolism/Other-Other

Neuroscience-Other Neuroscience

Oncology-RYBREVANT/LAZCLUZE

Neuroscience-CAPLYTA

Oncology-TECVAYLI

Neuroscience-CONCERTA/methylphenidate

Oncology- ZYTIGA /abirateroneacetate

Oncology-TALVEY

Cardiovascular-OTHER CARDIOVASCULAR

MedTech-Cardiovascular-OTHER CARDIOVASCULAR

Oncology-Other Oncology

Pulmonary Hypertension-OTHER PULMONARY HYPERTENSION

Infectious Diseases-Other Infectious Diseases

Immunology-Other Immunology

Interventional Solutions

Orthopaedics-Spine & Other

Pulmonary Hypertension-Other

Infectious Diseases-COVID-19 VACCINE

Interventional Solutions-Electrophysiology

Interventional Solutions-Other Interventional Solutions

Interventional Solutions-Abiomed

Over-the-Counter

Skin Health/Beauty

Oral Care

Baby Care

Womens Health

CarCardiovascular/Metabolism/Other-INVOKANA/INVOKAMET

Wound Care/Other

Neuroscience-RISPERDALCONSTA

Cardiovascular/Metabolism/Other-PROCRIT/EPREX

Oncology-VELCADE

Surgery-Specialty

Diabetes Care

Pulmonary Hypertension-TRACLEER

Diagnostics

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Oncology-DARZALEX

108.54B(48.35%)

100.49B(45.10%)

9.74B(7.79%)

7.98B(7.40%)

6.02B(7.65%)

4.19B(4.07%)

3.00B(2.84%)

2.02B(2.48%)

Immunology-STELARA

6.08B(2.71%)

10.36B(4.65%)

10.86B(8.68%)

9.72B(9.03%)

9.13B(11.60%)

7.71B(7.49%)

6.36B(6.03%)

5.16B(6.32%)

Cardiovascular-ELECTROPHYSIOLOGY

5.63B(2.51%)

5.27B(2.36%)

4.69B(3.75%)

--(--)

MedTech-Cardiovascular-ELECTROPHYSIOLOGY

5.63B(2.51%)

5.27B(2.36%)

4.69B(3.75%)

3.94B(3.65%)

--(--)

Surgery-General

5.56B(2.48%)

5.36B(2.40%)

5.37B(4.29%)

5.12B(4.75%)

--(--)

4.39B(4.27%)

5.41B(5.12%)

--(--)

MedTech-Surgery-General

5.56B(2.48%)

5.36B(2.40%)

5.37B(4.29%)

5.12B(4.75%)

5.19B(6.59%)

4.39B(4.27%)

5.41B(5.12%)

4.56B(5.59%)

Immunology-TREMFYA

5.16B(2.30%)

3.67B(1.65%)

3.15B(2.52%)

2.67B(2.48%)

2.13B(2.70%)

1.35B(1.31%)

1.01B(0.96%)

544.00M(0.67%)

Surgery-Advanced

4.58B(2.04%)

4.49B(2.01%)

4.67B(3.73%)

4.57B(4.24%)

--(--)

3.84B(3.73%)

4.09B(3.88%)

--(--)

MedTech-Surgery-Advanced

4.58B(2.04%)

4.49B(2.01%)

4.67B(3.73%)

4.57B(4.24%)

4.62B(5.87%)

3.84B(3.73%)

4.09B(3.88%)

4.00B(4.91%)

Vision-Contact Lenses/Other

3.91B(1.74%)

3.73B(1.68%)

3.70B(2.96%)

3.54B(3.29%)

--(--)

2.99B(2.91%)

3.39B(3.22%)

--(--)

MedTech-Vision-Contact Lenses/Other

3.91B(1.74%)

3.73B(1.68%)

3.70B(2.96%)

3.54B(3.29%)

3.44B(4.37%)

2.99B(2.91%)

3.39B(3.22%)

3.30B(4.05%)

Neuroscience-INVEGASUSTENNA/XEPLION/INVEGATRINZA/TREVICTA

3.81B(1.70%)

4.22B(1.89%)

4.12B(3.29%)

4.14B(3.84%)

4.02B(5.11%)

3.65B(3.55%)

3.33B(3.16%)

2.93B(3.59%)

Oncology-ERLEADA

3.57B(1.59%)

3.00B(1.35%)

2.39B(1.91%)

1.88B(1.75%)

1.29B(1.64%)

760.00M(0.74%)

332.00M(0.31%)

--(--)

Orthopaedics-Trauma

3.15B(1.40%)

3.05B(1.37%)

2.98B(2.38%)

2.87B(2.67%)

--(--)

2.61B(2.54%)

2.72B(2.58%)

--(--)

MedTech-Orthopaedics-Trauma

3.15B(1.40%)

3.05B(1.37%)

2.98B(2.38%)

2.87B(2.67%)

2.88B(3.66%)

2.61B(2.54%)

2.72B(2.58%)

2.70B(3.31%)

Orthopaedics-SPINE, SPORTS & OTHER

2.85B(1.27%)

2.93B(1.31%)

2.95B(2.36%)

--(--)

MedTech-Orthopaedics-SPINE, SPORTS & OTHER

2.85B(1.27%)

2.93B(1.31%)

2.95B(2.36%)

2.84B(2.64%)

2.90B(3.68%)

2.70B(2.62%)

3.20B(3.03%)

3.27B(4.00%)

Oncology-IMBRUVICA

2.82B(1.26%)

3.04B(1.36%)

3.26B(2.61%)

3.78B(3.51%)

4.37B(5.55%)

4.13B(4.01%)

3.41B(3.23%)

2.62B(3.21%)

Immunology-SIMPONI/SIMPONI ARIA

2.67B(1.19%)

2.19B(0.98%)

2.20B(1.76%)

2.18B(2.03%)

2.28B(2.89%)

2.24B(2.18%)

2.19B(2.07%)

2.08B(2.55%)

Cardiovascular/Metabolism/Other-XARELTO

2.63B(1.17%)

2.37B(1.06%)

2.37B(1.89%)

2.47B(2.30%)

2.44B(3.10%)

2.35B(2.28%)

2.31B(2.19%)

2.48B(3.04%)

Pulmonary Hypertension-OPSUMIT/OPSYNVI

2.33B(1.04%)

2.23B(1.00%)

--(--)

Pulmonary Hypertension-OPSUMIT

2.33B(1.04%)

2.23B(1.00%)

1.97B(1.58%)

1.78B(1.66%)

1.82B(2.31%)

1.64B(1.59%)

1.33B(1.26%)

1.22B(1.49%)

Pulmonary Hypertension-UPTRAVI

1.90B(0.85%)

1.82B(0.82%)

1.58B(1.26%)

1.32B(1.23%)

1.24B(1.57%)

1.09B(1.06%)

819.00M(0.78%)

663.00M(0.81%)

Oncology-CARVYKTI

1.89B(0.84%)

963.00M(0.43%)

500.00M(0.40%)

133.00M(0.12%)

--(--)

Immunology-REMICADE

1.77B(0.79%)

1.60B(0.72%)

1.84B(1.47%)

2.34B(2.17%)

3.19B(4.05%)

3.75B(3.64%)

4.38B(4.15%)

5.33B(6.53%)

Cardiovascular-ABIOMED

1.75B(0.78%)

1.50B(0.67%)

1.31B(1.04%)

--(--)

MedTech-Cardiovascular-ABIOMED

1.75B(0.78%)

1.50B(0.67%)

1.31B(1.04%)

31.00M(0.03%)

--(--)

Neuroscience-SPRAVATO

1.70B(0.76%)

1.08B(0.48%)

689.00M(0.55%)

374.00M(0.35%)

224.00M(0.28%)

--(--)

Orthopaedics-Hips

1.67B(0.75%)

1.64B(0.74%)

1.56B(1.25%)

1.51B(1.41%)

--(--)

1.28B(1.24%)

1.44B(1.36%)

--(--)

MedTech-Orthopaedics-Hips

1.67B(0.75%)

1.64B(0.74%)

1.56B(1.25%)

1.51B(1.41%)

1.48B(1.88%)

1.28B(1.24%)

1.44B(1.36%)

1.42B(1.74%)

Orthopaedics-Knees

1.59B(0.71%)

1.54B(0.69%)

1.46B(1.16%)

1.36B(1.26%)

--(--)

1.17B(1.14%)

1.48B(1.40%)

--(--)

MedTech-Orthopaedics-Knees

1.59B(0.71%)

1.54B(0.69%)

1.46B(1.16%)

1.36B(1.26%)

1.32B(1.68%)

1.17B(1.14%)

1.48B(1.40%)

1.50B(1.84%)

Infectious Diseases-PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA

1.58B(0.70%)

1.71B(0.77%)

1.85B(1.48%)

1.94B(1.80%)

2.08B(2.65%)

2.18B(2.12%)

2.11B(2.00%)

1.96B(2.40%)

Vision-Surgical

1.56B(0.69%)

1.41B(0.63%)

1.37B(1.09%)

1.31B(1.21%)

--(--)

925.00M(0.90%)

1.23B(1.17%)

--(--)

MedTech-Vision-Surgical

1.56B(0.69%)

1.41B(0.63%)

1.37B(1.09%)

1.31B(1.21%)

1.25B(1.58%)

925.00M(0.90%)

1.23B(1.17%)

1.25B(1.53%)

Infectious Diseases- EDURANT/rilpivirine

1.49B(0.66%)

1.27B(0.57%)

1.15B(0.92%)

1.01B(0.94%)

994.00M(1.26%)

964.00M(0.94%)

861.00M(0.82%)

816.00M(1.00%)

Cardiovascular-SHOCKWAVE

1.15B(0.51%)

564.00M(0.25%)

--(--)

MedTech-Cardiovascular-SHOCKWAVE

1.15B(0.51%)

564.00M(0.25%)

--(--)

Cardiovascular/Metabolism/Other-Other

1.15B(0.51%)

1.19B(0.53%)

1.31B(1.04%)

1.41B(1.31%)

1.68B(2.14%)

1.39B(1.35%)

1.35B(1.28%)

1.47B(1.80%)

Neuroscience-Other Neuroscience

1.05B(0.47%)

1.18B(0.53%)

1.55B(1.24%)

1.73B(1.61%)

2.07B(2.63%)

1.61B(1.56%)

1.61B(1.53%)

1.75B(2.14%)

Oncology-RYBREVANT/LAZCLUZE

734.00M(0.33%)

327.00M(0.15%)

--(--)

Neuroscience-CAPLYTA

700.00M(0.31%)

--(--)

Oncology-TECVAYLI

670.00M(0.30%)

549.00M(0.25%)

395.00M(0.32%)

15.00M(0.01%)

--(--)

Neuroscience-CONCERTA/methylphenidate

584.00M(0.26%)

641.00M(0.29%)

783.00M(0.63%)

644.00M(0.60%)

667.00M(0.85%)

622.00M(0.60%)

696.00M(0.66%)

663.00M(0.81%)

Oncology- ZYTIGA /abirateroneacetate

502.00M(0.22%)

631.00M(0.28%)

887.00M(0.71%)

1.77B(1.64%)

2.30B(2.92%)

2.47B(2.40%)

2.79B(2.65%)

3.50B(4.29%)

Oncology-TALVEY

463.00M(0.21%)

287.00M(0.13%)

--(--)

Cardiovascular-OTHER CARDIOVASCULAR

397.00M(0.18%)

380.00M(0.17%)

356.00M(0.28%)

--(--)

MedTech-Cardiovascular-OTHER CARDIOVASCULAR

397.00M(0.18%)

380.00M(0.17%)

356.00M(0.28%)

332.00M(0.31%)

--(--)

Oncology-Other Oncology

376.00M(0.17%)

317.00M(0.14%)

484.00M(0.39%)

423.00M(0.39%)

568.00M(0.72%)

821.00M(0.80%)

407.00M(0.39%)

590.00M(0.72%)

Pulmonary Hypertension-OTHER PULMONARY HYPERTENSION

209.00M(0.09%)

240.00M(0.11%)

260.00M(0.21%)

313.00M(0.29%)

395.00M(0.50%)

416.00M(0.40%)

476.00M(0.45%)

149.00M(0.18%)

Infectious Diseases-Other Infectious Diseases

175.00M(0.08%)

412.00M(0.18%)

297.00M(0.24%)

318.00M(0.30%)

363.00M(0.46%)

396.00M(0.38%)

441.00M(0.42%)

533.00M(0.65%)

Immunology-Other Immunology

61.00M(0.03%)

3.00M(--)

11.00M(0.01%)

17.00M(0.02%)

24.00M(0.03%)

11.00M(0.01%)

10.00M(0.01%)

Interventional Solutions

--(--)

7.71B(3.46%)

6.35B(5.08%)

4.30B(3.99%)

--(--)

3.05B(2.96%)

3.00B(2.84%)

2.65B(3.24%)

Orthopaedics-Spine & Other

--(--)

2.93B(1.31%)

2.95B(2.36%)

2.84B(2.64%)

--(--)

2.70B(2.62%)

3.20B(3.03%)

--(--)

Pulmonary Hypertension-Other

--(--)

281.00M(0.13%)

260.00M(0.21%)

313.00M(0.29%)

--(--)

416.00M(0.40%)

476.00M(0.45%)

--(--)

Infectious Diseases-COVID-19 VACCINE

--(--)

198.00M(0.09%)

1.12B(0.89%)

2.18B(2.02%)

2.38B(3.03%)

--(--)

Interventional Solutions-Electrophysiology

--(--)

3.62B(4.60%)

--(--)

Interventional Solutions-Other Interventional Solutions

--(--)

348.00M(0.44%)

--(--)

Interventional Solutions-Abiomed

--(--)

Over-the-Counter

--(--)

5.22B(5.07%)

4.44B(4.21%)

4.33B(5.31%)

Skin Health/Beauty

--(--)

4.45B(4.32%)

4.59B(4.35%)

4.38B(5.37%)

Oral Care

--(--)

1.64B(1.59%)

1.53B(1.45%)

1.55B(1.91%)

Baby Care

--(--)

1.52B(1.47%)

1.68B(1.59%)

1.86B(2.28%)

Womens Health

--(--)

901.00M(0.88%)

986.00M(0.93%)

1.05B(1.29%)

CarCardiovascular/Metabolism/Other-INVOKANA/INVOKAMET

--(--)

795.00M(0.77%)

735.00M(0.70%)

881.00M(1.08%)

Wound Care/Other

--(--)

720.00M(0.70%)

671.00M(0.64%)

675.00M(0.83%)

Neuroscience-RISPERDALCONSTA

--(--)

642.00M(0.62%)

688.00M(0.65%)

737.00M(0.90%)

Cardiovascular/Metabolism/Other-PROCRIT/EPREX

--(--)

790.00M(0.75%)

988.00M(1.21%)

Oncology-VELCADE

--(--)

751.00M(0.71%)

1.12B(1.37%)

Surgery-Specialty

--(--)

1.34B(1.64%)

Diabetes Care

--(--)

1.01B(1.24%)

Pulmonary Hypertension-TRACLEER

--(--)

546.00M(0.67%)

Diagnostics

--(--)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

International

Europe

Asia-Pacific, Africa

Western Hemisphere, excluding U.S.

Asia/Pacific-Oceania/Africa

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

53.75B(39.92%)

50.30B(39.50%)

46.44B(37.49%)

41.98B(35.58%)

40.64B(34.78%)

43.13B(35.34%)

42.10B(34.50%)

41.88B(34.54%)

39.86B(52.14%)

37.81B(52.60%)

35.69B(50.93%)

34.78B(46.79%)

31.91B(44.75%)

29.83B(44.37%)

28.91B(44.45%)

International

40.44B(30.04%)

38.52B(30.25%)

38.72B(31.25%)

38.01B(32.21%)

38.10B(32.61%)

39.45B(32.33%)

39.96B(32.75%)

39.70B(32.73%)

--(--)

Europe

21.54B(16.00%)

20.21B(15.87%)

20.41B(16.48%)

20.66B(17.51%)

20.59B(17.63%)

18.98B(15.55%)

18.47B(15.13%)

18.75B(15.46%)

17.13B(22.40%)

15.77B(21.94%)

15.99B(22.83%)

18.95B(25.49%)

18.60B(26.08%)

16.95B(25.21%)

17.13B(26.34%)

Asia-Pacific, Africa

14.03B(10.42%)

13.59B(10.67%)

13.76B(11.10%)

13.24B(11.22%)

13.58B(11.62%)

15.14B(12.40%)

15.55B(12.75%)

14.83B(12.23%)

13.42B(17.55%)

--(--)

Western Hemisphere, excluding U.S.

4.88B(3.62%)

4.71B(3.70%)

4.55B(3.67%)

4.11B(3.48%)

3.93B(3.36%)

5.33B(4.37%)

5.94B(4.87%)

6.11B(5.04%)

6.04B(7.90%)

5.73B(7.98%)

6.04B(8.63%)

7.16B(9.63%)

7.42B(10.41%)

7.21B(10.72%)

6.42B(9.87%)

Asia/Pacific-Oceania/Africa

--(--)

12.57B(17.49%)

12.35B(17.62%)

13.44B(18.08%)

13.38B(18.77%)

13.24B(19.70%)

12.57B(19.34%)